You have 9 free searches left this month | for more free features.

Condition

Breast Cancer (1)

Cancer (1)

Carcinoma, Hepatocellular (1)

Overall Status

Completed (2)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

GlaxoSmithKline (2)

NCIC Clinical Trials Group (1)

Collaborator

GlaxoSmithKline (1)

Intervention

foretinib (3)

erlotinib (1)

lapatinib (1)

Study Documents

Clinical Study Report (1)

Dataset Specification (1)

Individual Participant Data Set (1)

Informed Consent Form (1)

Statistical Analysis Plan (1)

Study Protocol (1)

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

foretinib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Cancer Trial in Canada (Foretinib, Lapatinib)

Completed

Breast Cancer

Foretinib
Lapatinib

Kelowna, British Columbia, Canada
+4 more

Sep 16, 2020

Carcinoma, Hepatocellular Trial in Hong Kong, Taiwan, Thailand (Foretinib)

Completed

Carcinoma, Hepatocellular

Foretinib

Hong Kong, Hong Kong
+6 more

Jul 14, 2017

Cancer Trial (Foretinib, Erlotinib)

Withdrawn

Cancer

Foretinib
Erlotinib

(no location specified)

May 15, 2014